Physician profile
Robert W Patterson
NPI 1346214079
$201.17
in general payments reported to CMS, 2019-2025
7 companies · $86.19 in 2025
The $86.19 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.28 · 2021: $22.72 · 2022: $15.01 · 2023: $18.63 · 2024: $46.34 · 2025: $86.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $91.79 | 2024-2025 | Eterna, Proclaim |
| Seqirus USA INC | $26.27 | 2025 | Flucelvax, Fluad |
| Novo Nordisk INC | $22.72 | 2021 | |
| Heron Therapeutics, INC. | $18.63 | 2023 | Zynrelef |
| Abbvie INC. | $15.01 | 2022 | |
| Csl Behring | $14.47 | 2024 | Kcentra |
| Merck Sharp & Dohme LLC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.